When Multiple Vaccines Are Given Together

Why This Analysis Matters

Understanding co-administration patterns in VAERS is essential because a large share of adverse event reports involve more than one vaccine. When a report lists multiple vaccines, VAERS counts it under each — which means raw per-vaccine counts can overstate the true number of unique adverse events. This article provides the context needed to interpret multi-vaccine VAERS data accurately.

Co-Administration is Standard Practice

Administering multiple vaccines during a single visit is routine medical practice, especially for children following the CDC's recommended immunization schedule. The 1,514different vaccine combinations in VAERS reflect this standard approach to vaccination. Understanding these co-administration patterns is essential for correctly interpreting VAERS reports, since a single adverse event reported after multiple vaccines appears in the data for each vaccine listed.

The World Health Organization, the American Academy of Pediatrics, and every major medical organization endorse co-administration of vaccines when recommended by the immunization schedule. This practice is supported by decades of clinical evidence.

Co-administration offers several advantages: fewer clinic visits, better adherence to vaccination schedules, reduced costs, and earlier protection. Extensive studies have shown that giving multiple vaccines together is safe and effective. The alternative — spreading vaccines across many separate visits — is not recommended by any major medical organization and leaves children unprotected for longer periods during their most vulnerable years.

Terminology: Co-Administration vs Combination Vaccines

It is important to distinguish between co-administration (giving separate vaccines at the same visit) and combination vaccines (single products containing multiple antigens, like MMR or Pediarix). This analysis focuses on co-administration — reports where two or more separate vaccine products were given together.

The Most Common Combinations

The most frequently reported combination involves FLU3 + PPV, with 11,961VAERS reports. This high number likely reflects both the frequency of this combination and the volume of reports during specific time periods.

Many of the top combinations involve routine childhood vaccines or seasonal influenza vaccines given alongside other routine immunizations.

Pediatric Vaccination Combinations

Pediatric vaccine combinations represent a significant portion of co-administration reports. The CDC's childhood immunization schedule often calls for multiple vaccines at single visits:

• 2-month visit: DTaP, IPV, Hib, PCV13, and Rotavirus
• 4-month visit: Same combination as 2 months
• 12-15 month visit: MMR, Varicella, Hib, PCV13

These combinations have been extensively studied and are designed to provide optimal protection while minimizing the number of healthcare visits required.

COVID-19 Vaccine Combinations

COVID-19 vaccines have been administered alongside other vaccines, particularly seasonal influenza vaccines. Initially, CDC recommended spacing between COVID-19 vaccines and other vaccines, but this guidance was updated to allow co-administration based on safety data.

The most common COVID-19 combination reported involves COVID19 + UNK, with 4,771 reports.

Safety Considerations

When evaluating adverse events after multiple vaccines, determining attribution becomes more complex. Key considerations include:

• Expected reactions: Each vaccine can cause its own set of expected side effects
• Immune system stimulation: Multiple vaccines may temporarily increase inflammatory responses
• Injection site reactions: Multiple injection sites can mean multiple areas of local reactions
• Temporal associations: Adverse events may be attributed to the combination when they might have occurred with any single vaccine

Clinical Trial Evidence

Before vaccines are approved for co-administration, clinical trials specifically study combination safety:

• Immune response studies ensure vaccines don't interfere with each other
• Safety studies compare side effect rates for combinations vs. individual vaccines
• Long-term follow-up assesses for any delayed effects

These studies consistently show that co-administration is as safe as giving vaccines separately, with similar immune responses and side effect profiles.

Common Concerns About Multiple Vaccines

Parents and patients sometimes express concern about receiving multiple vaccines at once. Common questions include:

• "Won't it overwhelm the immune system?" No. The immune system encounters thousands of antigens daily from food, air, and skin contact. The antigens in all childhood vaccines combined represent a tiny fraction of what the immune system routinely handles.
• "Shouldn't we spread them out?" Delaying vaccines leaves children unprotected during their most vulnerable period. The CDC schedule is designed to provide protection as early as safely possible. Alternative schedules are not recommended by any major medical organization.
• "Are combination shots safer than separate shots?" Combination vaccines (like MMR or DTaP) reduce the number of injections while providing the same protection. They undergo the same rigorous testing as individual vaccines.

VAERS Reporting for Multi-Vaccine Events

When an adverse event is reported after multiple vaccines are given together, VAERS lists all vaccines administered. This means a single report may appear in the data for each vaccine involved, which can inflate apparent report counts for individual vaccines. Analysts must account for this overlap when examining vaccine-specific data.

Our multi-vaccine tool lets you explore the most common co-administration combinations and their associated report patterns interactively.

Interpreting Co-Administration Reports

VAERS reports involving multiple vaccines require careful interpretation:

• The total number of reports may be higher simply because more vaccines are involved
• Mild reactions like fever may be more common but are still generally expected
• Serious adverse events need evaluation to determine if they're related to any specific vaccine or the combination
• Background rates of health events in the vaccinated population must be considered